Vaccines
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
60
NCT05805618
Evaluation of Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects
Phase: Early Phase 1
Role: Collaborator
Start: Jul 1, 2024
Completion: Nov 1, 2024
Loading map...